| |
|
Expiry Date or Comments |
| |
NHSGGC Policy Development Framework (NHS network access required) |
|
| Governance Advisory Structure and Managed Entry of Medicines |
| 1.1 |
Medicines Advisory Structure |
Feb 2028
|
| 1.2 |
Managed Entry of New Medicines |
Feb 2028 |
| 1.3 |
Managed Introduction of New Oncology Medicines |
Under review
Nov 25
|
| ADTC and Subcommittees |
| 2.1 |
Area Drug and Therapeutics Committee: Terms of Reference |
Oct 2026 |
| 2.2 |
Medicines Utilisation Subcommittee: Terms of Reference |
Jan 2028 |
| 2.3 |
Prescribing Interface Subcommittee: Terms of Reference |
March 2027 |
| 2.4 |
Non-Medicines Utilisation Subcommittee: Terms of Reference |
June 2028 |
| 2.4.1 |
Processes related to the Non-Medicines Formularies |
April 2027 |
| 2.5 |
Communications Subcommittee: Terms of Reference |
May 2027 |
| 2.6 |
Antimicrobial Utilisation Subcommittee: Terms of Reference |
Aug 2027 |
| 2.7 |
Safer Use of Medicines Subcommittee: Terms of Reference |
Oct 2026 |
| 2.8 |
Patient Group Direction Subcommittee: Terms of Reference |
Oct 2026 |
| Formulary Management |
| 3.1 |
Formulary Management Policy
You may also wish to refer to 3.1.1 Formulary Processes for Medical Devices, Non-Prescription Only Medicines (non-POMs) and Complimentary Medicines
|
Jan 2027
|
| Prescribing Management Groups (PMGs) |
| 4.2 |
Acute Services PMG: Terms of Reference |
July 2029 |
| 4.3 |
Primary Care PMG: Terms of Reference |
Dec 2026 |
| 4.5 |
PMG Mental Health: Terms of Reference |
Feb 2029 |
| Access to Medicines |
| 5.1 |
Non-Formulary Prescribing Policy |
Aug 2028 |
| 5.2 |
Peer Approved Clinical System (PACS Tier Two) Policy For related info and documentation, see HERE |
Dec 2028 |
| 5.4 |
Management of Individual Patient Treatment Requests (IPTRs) |
Dec 2028
|
| 5.5 |
Individual Patient Treatment Request (IPTR) Appeal process |
Dec 2028 |
| 5.6 |
Co-Payment Policy |
Oct 2028 |
| 5.6.1 |
Co-Payment Form (CPF1) |
Oct 2028 |
| 5.7 |
Acute Unlicensed Medicines Policy (ULM Policy) |
Jan 2027 |
| 5.8 |
Guidance for Medicines Access Schemes |
Oct 2028 |
| 5.9 |
Ultra-Orphan Pathway |
New: in development
Nov 25
|
| 5.10 |
Supply of Medicines Following Specialist Review or Clinic Appointments |
May 2028 |
| 5.10.1 |
Supply of Medicines Following Specialist Review - Additional Guidance for Mental Health |
Aug 2027 |
| Clinical policies, including Handling of Medicines |
| 6.1 |
Safe and Secure Handling of Medicines Policy and Guidance |
|
| 6.2A |
Administration of Intravenous (IV) Medicines and Flush Policy |
Via Clinical Guidelines |
| 6.2B |
Addendum to Administration of IV Medicines and Flush Policy |
Sept 2026 |
| 6.4 |
Policy and Registers for Non-Cytotoxic Intrathecal and Intraventricular Injections
|
Policy: October 2028
|
| 6.5 |
Medicines Reconciliation in Hospital |
March 2028 |
| Clinical Guidelines |
| 7.1 |
Clinical Guidelines Framework |
Via Clinical Guidelines |
| 7.2 |
Development and Review Process and Clinical Guideline Title Page |
Via Clinical Guidelines |
| 7.3 |
Electronic Checklists for submission of Clinical Guidelines |
Via Clinical Guidelines |
| 7.4 |
AUC Antimicrobial Guideline Approval Process |
Aug 2027 |
| Miscellaneous |
| 8.1 |
Suspected Medicines Defect Policy |
Nov 2027 |
| 8.1.1 |
Suspected Medicines Defect Reporting Form (for use by acute pharmacy staff) |
Nov 2027 |
| 8.2 |
Symptomatic Relief Policy (Adults) |
Sept 2028 |
| 8.3 |
Medicines Alert and recall policy
NHSGGC chain of communications relating to medicines alerts
|
May 2027 |
| 8.4 |
PPSU Medicines Shortages Guidance via StaffNet |
Under review
2021
|
| 8.4.1 |
Patient Group Directions: Management of medicines shortages |
Dec 2027 |
| 8.4.2 |
Primary Care Medicine Shortage Guidance |
Apr 2028 |
| 8.5.1 |
Non-medical prescribing policy |
Apr 2028 |
| 8.5.2 |
Non-medical prescribing guidance |
June 2028 |
